Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer Therapy
Jian Zou(Central South University), Fang Wu(Central South University), Chaoyue Xiao(Central South University), Junqi Liu(First Affiliated Hospital of Zhengzhou University), Yingzhe Zhang(Central South University), Yue Zeng(The University of Texas MD Anderson Cancer Center), Yurong Peng(Central South University)
Cited by 19
Related Papers
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
|Frontiers in Oncology|2021|111
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
|Diabetes Research and Clinical Practice|2014|92
Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments
|Frontiers in Cell and Developmental Biology|2021|78